These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18834895)

  • 21. The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women's Health in the Lund Area (WHILA) study.
    Teleman PM; Persson J; Mattiasson A; Samsioe G
    Acta Obstet Gynecol Scand; 2009; 88(8):927-32. PubMed ID: 19579140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardizing lung function laboratories for multicenter trials.
    Beardsmore CS; Paton JY; Thompson JR; Laverty A; King C; Oliver C; Stocks J
    Pediatr Pulmonol; 2007 Jan; 42(1):51-9. PubMed ID: 17106901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New common reference intervals for clinical chemistry in the Nordic countries. A better basis for clinical assessment and cooperation].
    Simonsson P; Mårtensson A; Rustad P
    Lakartidningen; 2004 Mar; 101(10):901-5. PubMed ID: 15055053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A world apart: Inaccuracies of laboratory methodologies in antidoping testing.
    Banfi G; Lombardi G; Colombini A; Lippi G
    Clin Chim Acta; 2010 Aug; 411(15-16):1003-8. PubMed ID: 20362564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wide variability in laboratory reference values for serum testosterone.
    Lazarou S; Reyes-Vallejo L; Morgentaler A
    J Sex Med; 2006 Nov; 3(6):1085-1089. PubMed ID: 17100942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation.
    Munteanu M; Imbert-Bismut F; Housset C; Messous D; Fellahi S; Poynard T
    Clin Chim Acta; 2010 Feb; 411(3-4):292-3. PubMed ID: 19931523
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrated Diseases Surveillance Project (IDSP) through a consultant's lens.
    Suresh K
    Indian J Public Health; 2008; 52(3):136-43. PubMed ID: 19189835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretative reports and critical values.
    Piva E; Plebani M
    Clin Chim Acta; 2009 Jun; 404(1):52-8. PubMed ID: 19306860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardization in laboratory medicine: new challenges.
    Panteghini M; Forest JC
    Clin Chim Acta; 2005 May; 355(1-2):1-12. PubMed ID: 15820472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AutoAbSC.Org -- Autoantibody Standardization Committee in 2006.
    Chan EK; Fritzler MJ; Wiik A; Andrade LE; Reeves WH; Tincani A; Meroni PL;
    Autoimmun Rev; 2007 Sep; 6(8):577-80. PubMed ID: 17854752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
    Mullins C; Kaplan SA
    J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons from a project to create performance measures for public health.
    Hubley T
    Eval Program Plann; 2008 Nov; 31(4):410-5. PubMed ID: 18814912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CDC VITAL-EQA program, external quality assurance for serum retinol, 2003-2006.
    Haynes BM; Schleicher RL; Jain RB; Pfeiffer CM
    Clin Chim Acta; 2008 Apr; 390(1-2):90-6. PubMed ID: 18237548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estradiol and testosterone in specific regions of the human female brain in different endocrine states.
    Bixo M; Bäckström T; Winblad B; Andersson A
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):297-303. PubMed ID: 8541226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the public health research agenda for ovarian cancer.
    Trivers KF; Stewart SL; Peipins L; Rim SH; White MC
    J Womens Health (Larchmt); 2009 Sep; 18(9):1299-305. PubMed ID: 19702475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention.
    Albright A; Burrows NR; Jordan R; Williams DE
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S121-5. PubMed ID: 19231756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building the nation's first institute for laboratory quality.
    Stombler RE
    Clin Lab Med; 2008 Jun; 28(2):179-87, v. PubMed ID: 18436065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpretative commenting: a tool for improving the laboratory-clinical interface.
    Plebani M
    Clin Chim Acta; 2009 Jun; 404(1):46-51. PubMed ID: 19298798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirements for facilities transferring or receiving select agents. Final rule.
    Center for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2001 Aug; 66(170):45944-5. PubMed ID: 11757572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persons and institutions involved in the NORIP project.
    Scand J Clin Lab Invest; 2004; 64(4):267-70. PubMed ID: 15223693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.